|
|
News Breaks | | | | December 31, 2012 | | 08:08 EDT |  | COV | Covidien raises FY13 Phamaceutical unit sales growth guidance to up 3%-6%
Covidien announced that as a result of the FDA approval of its generic version of CONCERTA and continued good operational performance, Covidien is increasing the fiscal 2013 net sales guidance for the Pharmaceuticals segment to 3%-6% above 2012 from the previous range of 1%-4% above 2012. There are no other changes to Covidien’s previously announced 2013 guidance, the company said, adding that more details will be provided on January 25, 2013, when the company announces its first-quarter results. Covidien announced in December 2011 that it plans to spin off its Pharmaceuticals segment, Mallinckrodt, into a stand-alone company, a process expected to be completed in mid-2013. | |
|
News For COV From The Last 14 Days Check below for free stories on COV the last two weeks. |
|
|
| May 16, 2013 | | 07:28 EDT |  | COV | I/O Central to host a conference
 Subscribe for More Information | | | May 10, 2013 | | 06:16 EDT |  | COV | Obesity surgery booming in India, Bloomberg reports
Subscribe for More Information | | | May 8, 2013 | | 07:38 EDT | | COV | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information | | | May 7, 2013 | | 07:24 EDT | | COV | Mizuho Securities to host a conference
Subscribe for More Information | | | May 6, 2013 | | 07:18 EDT | | COV | American Congress of Obstetrics and Gynecology to hold annual meeting
Subscribe for More Information | | | 05:57 EDT | | COV | Covidien to host conference call
Subscribe for More Information | |
|
|
|
|
|
|
